Development of tissue-engineered models of oral dysplasia and early invasive oral squamous cell carcinoma.
about
Fibronectin Modulates Cell Adhesion and Signaling to Promote Single Cell Migration of Highly Invasive Oral Squamous Cell CarcinomaInhibition of αvβ3 integrin induces loss of cell directionality of oral squamous carcinoma cells (OSCC)Raman spectroscopy can discriminate between normal, dysplastic and cancerous oral mucosa: a tissue-engineering approach.Cancer research by means of tissue engineering--is there a rationale?The role of HOXB9 and miR-196a in head and neck squamous cell carcinomaEstablishment of 3D Co-Culture Models from Different Stages of Human Tongue Tumorigenesis: Utility in Understanding Neoplastic ProgressionAlginate oligosaccharides modify hyphal infiltration of Candida albicans in an in vitro model of invasive human candidosis.Tissue-engineered oral mucosa.Tissue engineering of oral mucosa: a shared concept with skin.Angiotensin 1-7 inhibits angiotensin II-stimulated head and neck cancer progression.Cigarette smoke condensate promotes pro-tumourigenic stromal-epithelial interactions by suppressing miR-145.Polymeric drug delivery systems for intraoral site-specific chemoprevention of oral cancer.A miR-335/COX-2/PTEN axis regulates the secretory phenotype of senescent cancer-associated fibroblasts.Characterization of a functional C3A liver spheroid model.Tissue-engineered oral mucosa to study radiotherapy-induced oral mucositis.Biomarkers in Tumorigenesis Using Cancer Cell Lines: A Systematic ReviewUse of a Rho kinase inhibitor to increase human tonsil keratinocyte longevity for three-dimensional, tissue engineered tonsil epithelium equivalents.HPV-negative, but not HPV-positive, oropharyngeal carcinomas induce fibroblasts to support tumour invasion through micro-environmental release of HGF and IL-6.Denture-associated biofilm infection in three-dimensional oral mucosal tissue models.[Preclinical models in head and neck tumors : Evaluation of cellular and molecular resistance mechanisms in the tumor microenvironment].XRCC1 Arg399Gln polymorphism is not associated with oral cancer risk: evidence from a meta-analysis.XPD Lys751Gln polymorphism is not associated with oral cancer risk: evidence from a meta-analysis.
P2860
Q27317356-2361CA17-DD44-4D5C-B35F-D4E9B4D562A8Q30252508-7F2395D6-DF84-45F4-AE6F-C090C22BC31FQ30395350-17BC603D-49D9-4506-811F-B24A8B3C19A3Q34154747-9B75EA42-076E-4462-AB3D-B0903A0D6277Q35363995-9188D547-6869-4708-A1D8-28AE1D61C14CQ36097586-1D999BD7-2AC0-4BC8-A87B-7503F6B56A23Q36411038-D44CAF30-E259-4AB7-9AEF-402CF7790D7FQ37977812-D8E1A87E-316A-4274-BDFC-E645AB99A1C8Q38261154-6EA0F157-F2DA-404C-BCA4-3C17F3A81974Q38707625-8964A4DB-EB52-4D5C-9DA7-6920B343882DQ39240817-0A107BA9-97EE-4990-A2C6-7CC6393C2A2AQ39398234-FD6AEAF2-23A6-4D3A-AD72-68B737F3E85CQ39626176-E0B32F13-2307-4167-902C-AE0CFBB9DCE6Q41278185-3AE71CDE-A8AD-49F9-B5EF-1FC61EFB1C5FQ46105730-1FE3C7AA-2EE7-462A-8128-C06E10839AE6Q47131783-59E7BDE9-F68C-4D65-BFC0-74C44F3C5AB9Q47430084-64BE97EF-E8F3-4D19-A66B-3E10E0958F93Q47593658-74DAB3D0-0608-4B5B-8928-56A6E11B121DQ49837604-C833EFC4-203B-48B4-ADFD-59576F5E3198Q52815753-24F5E1D1-FED7-4EBF-9FF8-24CD8DD23909Q53126677-4FADDFC4-5268-44A9-ADD9-F738C716D460Q53139678-BC0044EA-5F3E-405C-8807-B3964EDA7ECF
P2860
Development of tissue-engineered models of oral dysplasia and early invasive oral squamous cell carcinoma.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh
2011年學術文章
@zh-hant
name
Development of tissue-engineer ...... oral squamous cell carcinoma.
@en
Development of tissue-engineer ...... oral squamous cell carcinoma.
@nl
type
label
Development of tissue-engineer ...... oral squamous cell carcinoma.
@en
Development of tissue-engineer ...... oral squamous cell carcinoma.
@nl
prefLabel
Development of tissue-engineer ...... oral squamous cell carcinoma.
@en
Development of tissue-engineer ...... oral squamous cell carcinoma.
@nl
P2093
P2860
P50
P356
P1476
Development of tissue-engineer ...... e oral squamous cell carcinoma
@en
P2093
H E Colley
S M Violette
V Hearnden
P2860
P2888
P304
P356
10.1038/BJC.2011.403
P407
P577
2011-10-11T00:00:00Z